Myriad Genetics (MYGN) Gross Margin (2009 - 2026)
Myriad Genetics (MYGN) posted quarterly Gross Margin of 68.66% for Q1 2026, up 16.0% year-over-year from 59.19% in Q1 2025, and down 1.87% quarter-over-quarter from 69.97% in Q4 2025.
Myriad Genetics (MYGN) Gross Margin (2009 - 2026) Analysis & Trends
Myriad Genetics (MYGN) has reported Gross Margin for 18 consecutive years, with 68.66% the latest figure, recorded in Q1 2026.
- In Q1 2026, Gross Margin rose 16.0% year-over-year to 68.66%; the TTM figure through Mar 2026 stood at 69.96% (down 5.0% YoY), while the FY2025 annual figure was 69.93%, up 4.0% from the prior year.
- Gross Margin declined to 68.66% in Q1 2026 per MYGN's latest filing, from 69.97% in the prior quarter.
- Across five years, Gross Margin topped out at 72.28% in Q2 2022 and bottomed at 67.33% in Q1 2023.
- Historically, Gross Margin has averaged 69.58% across 5 years, with a median of 69.69% in 2022.
- Annual changes were most pronounced in 2022 — Gross Margin slumped 2471 bps — and 2024, when it jumped 299 bps.
- Myriad Genetics' Gross Margin stood at 69.69% in 2022, then slipped by 1 bps to 68.67% in 2023, then gained by 4 bps to 71.65% in 2024, then slipped by 2 bps to 69.97% in 2025, then declined by 2 bps to 68.66% in 2026.
- Business Quant data shows MYGN's Gross Margin at 68.66% in Q1 2026, 69.97% in Q4 2025, and 69.91% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 69.57% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 57.64% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 64.04% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 53.95% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 32.85% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 99.91% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 66.44% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 63.29% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 33.75% |
| 10 | Myriad Genetics | 297.97 Mn | 173.57 Mn | 137.60 Mn | 68.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.66% |
| Dec 31, 2025 | 69.97% |
| Sep 30, 2025 | 69.91% |
| Jun 30, 2025 | 71.23% |
| Mar 31, 2025 | 68.50% |
| Dec 31, 2024 | 71.65% |
| Sep 30, 2024 | 70.23% |
| Jun 30, 2024 | 69.55% |
| Mar 31, 2024 | 68.05% |
| Dec 31, 2023 | 68.67% |
| Sep 30, 2023 | 69.98% |
| Jun 30, 2023 | 68.50% |
| Mar 31, 2023 | 67.33% |
| Dec 31, 2022 | 69.69% |
| Sep 30, 2022 | 67.77% |
| Jun 30, 2022 | 72.28% |
| Mar 31, 2022 | 70.89% |
| Dec 31, 2021 | 71.52% |
| Sep 30, 2021 | 71.43% |
| Jun 30, 2021 | 96.99% |